Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock

Conditions:   Septic Shock;   Sepsis;   Pathologic Processes;   Shock;   Systemic Inflammatory Response Syndrome;   Inflammation;   Infections Interventions:   Biological: Allogeneic umbilical cord-derived human mesenchymal stromal cells;   Other: Placebo Sponsors:   Ottawa Hospital Research Institute;   Canadian Institutes of Health Research (CIHR);   Stem Cell Network;   Canadian Critical Care Trials Group;   Center for Regenerative Therapies Dresden (CRTD) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials